Vyleesi® product results: 14% growth in prescriptions dispensed over prior quarter – 7 consecutive quarters of double digit growth. Click here to learn more ›

Palatin Technologies To Participate In The 25th Annual Piper Jaffray Healthcare Conference

CRANBURY, N.J., Dec. 2, 2013 /PRNewswire/ — Palatin Technologies, Inc. (NYSE MKT: PTN) announced today that Dr. Carl Spana, the Company’s chief executive officer, will participate in a “Fireside Chat” at the 25th Annual Piper Jaffray Healthcare Conference at 4:00 p.m. ET on December 4, 2013. The conference will be held at the New York Palace hotel in New York City.  A live audio broadcast will be available on the “Investors” section of Palatin’s website at www.palatin.com. The live audio broadcast will be available through December 10, 2013.

About Palatin Technologies, Inc.

Palatin Technologies, Inc. is a biopharmaceutical company developing targeted, receptor-specific peptide therapeutics for the treatment of diseases with significant unmet medical need and commercial potential. Palatin’s strategy is to develop products and then form marketing collaborations with industry leaders in order to maximize their commercial potential. For additional information regarding Palatin, please visit Palatin’s website at www.palatin.com.

SOURCE Palatin Technologies, Inc.

Scroll to Top